Stoyanova lab is excited to share our new publication on the American Journal of Clinical and Experimental Urology on identifying UCH-L1 as an important regulator of double-negative prostate cancer tumor growth and progression.
Congratulations, Dr. Shiqin (Laura) Liu and team!
Link to publication: https://pmc.ncbi.nlm.nih.gov/articles/PMC11578776/
Ubiquitin C-terminal hydrolase L1 is a regulator of tumor growth and metastasis in double-negative prostate cancer
